In a 2018 guidance, FDA explained that it would consider a compounded drug to be essentially a copy of a commercially available drug if it has (i) the same API, (ii) the same or similar dosage, and (iii) the same route of administration, unless a prescriber determines that there is a change, made for an identified individual patient, which produces, for that patient, a significant difference from the commercially available drug product. The guidance also explains that, if a change is made for an identified patient, the prescriber should document the determination on the prescription, and the notations should be specific
Clearly there is a particular type of FMS patient who presents with increased sympathetic nervous system function, anxiety and/or depression, and a history of poor sleep with associated fatigue and widespread soft-tissue tenderness
Theresa Dowell DPN, who has ME/CFS, reported that Dr
Therefore, it could be concluded that MVs were unlikely to have an adverse significant effect on the stemness potential of stem cells
Similarly, physical activity levels influence outcomessedentary individuals typically experience less benefit than those who incorporate regular exercise into their routine
Introduction Glutathione is an essential antioxidant naturally produced by the body